Home Cart Sign in  
Alternatived Products of [ 54745-74-3 ]
Product Citations

Product Details of [ 54745-74-3 ]

CAS No. :54745-74-3 MDL No. :MFCD09800611
Formula : C6H12ClNO Boiling Point : -
Linear Structure Formula :- InChI Key :XADOTNAXKKFKDY-UHFFFAOYSA-N
M.W : 149.62 Pubchem ID :21983536
Synonyms :

Calculated chemistry of [ 54745-74-3 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 9
Num. arom. heavy atoms : 0
Fraction Csp3 : 1.0
Num. rotatable bonds : 0
Num. H-bond acceptors : 2.0
Num. H-bond donors : 1.0
Molar Refractivity : 41.49
TPSA : 21.26 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.62 cm/s

Lipophilicity

Log Po/w (iLOGP) : 0.0
Log Po/w (XLOGP3) : 0.84
Log Po/w (WLOGP) : 0.56
Log Po/w (MLOGP) : 0.57
Log Po/w (SILICOS-IT) : 1.2
Consensus Log Po/w : 0.63

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -1.3
Solubility : 7.55 mg/ml ; 0.0505 mol/l
Class : Very soluble
Log S (Ali) : -0.87
Solubility : 20.2 mg/ml ; 0.135 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -0.81
Solubility : 23.1 mg/ml ; 0.154 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.97

Safety of [ 54745-74-3 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H315-H319-H335 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 54745-74-3 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 54745-74-3 ]

[ 54745-74-3 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 1260088-72-9 ]
  • [ 54745-74-3 ]
  • [ 1260090-93-4 ]
YieldReaction ConditionsOperation in experiment
With N-ethyl-N,N-diisopropylamine; In ethanol; N,N-dimethyl-formamide; at 45.0℃; for 65.0h;Inert atmosphere; Step 1-A 20 mL vial equipped with a stirring bar and a Teflon cap was charged with 8-oxa-3azabicyclo[3.2.1]octane hydrochloride (101 mg, 0.673 mmol) followed by p (112 mg, 0.511 mmol). The solids were dissolved in anhydrous ethanol/DMF and heated gently with a heating gun to effect dissolution. After cooling to room temperature, N,N diisopropylethylamine (0.5 mL, 2.56 mmol) was added via syringe, the vial flushed with nitrogen, capeed and placed in a pre heated 45 C. heating block. After heating for 65 h at 45 an aliquot was removed and the progress of the reaction determined by LC-MS. Compound (p) was completely consumed and the reaction worked up as described in Example 105 to afford 156 mg of crude compound (gx) as an off white solid. LC-MS and NMR indicated the crude product was of high purity and could be used directly in the next step: (gx)1H NMR (400 MHz, DMSO) delta 5.10 (s, 2H), 4.38 (br d, J=1.7 Hz, 2H), 3.73 (br s, 1H), 3.32 (s, 1H), 3.20 (d, J=12.2 Hz, 2H), 2.70 (dd, J=41.2, 15.4 Hz, 1H), 2.01-1.51 (m, 4H), 1.32 (s, 6H). LC-MS: m/z=+296.3(M+H)+.
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Similar Product of
[ 54745-74-3 ]

Chemical Structure| 280-13-7

A225534[ 280-13-7 ]

8-Oxa-3-azabicyclo[3.2.1]octane

Reason: Free-salt

Related Parent Nucleus of
[ 54745-74-3 ]

Other Aliphatic Heterocycles

Chemical Structure| 909186-56-7

[ 909186-56-7 ]

2-Oxa-5-azabicyclo[2.2.1]heptane hydrochloride

Similarity: 0.84

Chemical Structure| 31560-06-2

[ 31560-06-2 ]

(1S,4S)-2-Oxa-5-azabicyclo[2.2.1]heptane hydrochloride

Similarity: 0.84

Chemical Structure| 904316-92-3

[ 904316-92-3 ]

3-Oxa-8-azabicyclo[3.2.1]octane hydrochloride

Similarity: 0.73

Chemical Structure| 1354952-28-5

[ 1354952-28-5 ]

2-Oxa-5-azabicyclo[4.1.0]heptane hydrochloride

Similarity: 0.70

Chemical Structure| 178312-62-4

[ 178312-62-4 ]

1,4-Oxazepane hydrochloride

Similarity: 0.67

; ;